查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
再生医学市场 - 按类型（细胞治疗、组织工程、基因治疗）、按应用（肿瘤学、皮肤病学、肌肉骨骼、神经病学、心血管、伤口癒合、眼科）、全球预测（2023-2032）
市场调查报告书
商品编码
1373359

再生医学市场 - 按类型（细胞治疗、组织工程、基因治疗）、按应用（肿瘤学、皮肤病学、肌肉骨骼、神经病学、心血管、伤口癒合、眼科）、全球预测（2023-2032）

Regenerative Medicine Market - By Type (Cell Therapy, Tissue Engineering, Gene Therapy), By Application (Oncology, Dermatology, Musculoskeletal, Neurology, Cardiovascular, Wound Healing, Ophthalmology), Global Forecast (2023-2032)
出版日期: | 出版商: Global Market Insights Inc. | 英文 100 Pages | 商品交期: 2-3个工作天内

价格

2023年至2032年，再生医学市场规模将以20.4%的复合年增长率成长。全球人口老化正在增加慢性病的盛行率，对再生疗法产生了很高的需求。干细胞研究、基因治疗和组织工程的不断进步也扩大了治疗选择的可用性，使再生医学在全球范围内更加可行和有效。例如，2022年1月，诺华与Alnylam建立了策略伙伴关係，利用后者专有的siRNA技术来创造一种刺激功能性肝细胞再生的新疗法。

加速再生医学研发活动的投资和资金增加可归因于监管支持的激增和审批流程的简化。个人化医疗的潜力不断增长，以及为了吸引患者和医疗保健提供者而更加重视治疗以前无法治癒的疾病，也将有助于产业的扩张。

再生医学行业根据类型、应用和地区进行分类。

根据类型，在基因工程技术的进步和基因治疗研究资金激增的推动下，预计从 2032 年到 2032 年，基因治疗领域的行业价值将以复合年增长率大幅增长。基因疗法治疗以前无法治疗的遗传性疾病的潜力也将推动该细分市场的成长。

预计神经学应用领域在预测期内将在再生医学市场中占据相当大的收入份额。阿兹海默症和帕金森氏症等神经系统疾病的盛行率不断上升，正在为基于干细胞的创新疗法的开发让路。此外，人口老化的加剧和研究经费的增加将推动该领域的成长。

从地区来看，亚太地区再生医学产业将在 2023 年至 2032 年期间以强劲的复合年增长率扩张。这一增长可归因于该地区人口老化的加剧和医疗基础设施的增加。研发投资的增加以及有利的政府措施的推出也将有助于该地区再生疗法的需求不断增长。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：再生医学市场洞察

  • 产业格局
  • 产业影响力
    • 成长动力
      • 全球慢性病盛行率不断上升
      • 创新药物开发投资不断增加
      • 干细胞技术在疾病治疗的高度采用
      • 强大的潜在疗法产品线
    • 产业陷阱与挑战
      • 严格的监管框架
      • 与某些再生医学治疗相关的高成本
  • 成长潜力分析
  • COVID-19 影响分析
  • 监管环境
  • 波特的分析
  • PESTEL分析

第 4 章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 全球公司市占率分析
  • 竞争定位矩阵
  • 战略仪錶板

第 5 章：再生医学市场估计与预测：按类型，2018-2032

  • 主要动向：依类型
  • 细胞疗法
  • 组织工程
  • 基因治疗
  • 其他类型

第 6 章：再生医学市场估计与预测：按应用，2018-2032

  • 主要动向：按应用
  • 肿瘤学
  • 肌肉骨骼
  • 神经病学
  • 心血管
  • 伤口癒合
  • 眼科
  • 其他应用

第 7 章：再生医学市场估计与预测：按地区，2018-2032

  • 主要动向：按地区
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 瑞典
    • 荷兰人
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区

第 8 章：公司简介

  • Novartis AG
  • Amgen Inc.
  • Bristol Myers Squibb
  • BLUEBIRD BIO
  • GC Pharma
  • GlaxoSmithKline plc
  • ANTEROGEN
  • BIOSOLUTIONS
  • TERUMO BCT
  • AVITA MEDICAL
  • Smith and Nephew
  • ORGANOGENESIS
Product Code: 4571

Regenerative medicine market size will grow at 20.4% CAGR from 2023 to 2032. The aging global population is increasing the prevalence of chronic diseases, creating high demand for regenerative therapies. The rising advancements in stem cell research, gene therapy, and tissue engineering are also expanding the availability of treatment options for making regenerative medicine more viable and effective worldwide. For instance, in January 2022, Novartis initiated a strategic partnership with Alnylam to harness the latter's proprietary siRNA technology in a bid to create a new therapy for stimulating the regeneration of functional liver cells.

Increasing investments and funding for expediting research and development activities in regenerative medicine can be attributed to the surging regulatory support and streamlined approval processes. The rising potential for personalized medicine and the higher focus on treating previously incurable conditions for attracting both patients and healthcare providers will also contribute to the industry expansion.

The regenerative medicine industry is categorized based on type, application, and region.

Based on type, the industry value from the gene therapy segment is projected to increase at substantial CAGR from 2032 to 2032, driven by advancements in genetic engineering techniques and the surging funding for gene therapy research. The potential of gene therapy to treat previously untreatable genetic disorders will also push the segment growth.

The neurology application segment is anticipated to account for sizeable revenue share of the regenerative medicine market during the forecast period. The rising prevalence of neurological disorders, such as Alzheimer's and Parkinson's disease is making way for the development of innovative stem cell-based therapies. In addition, the growing aging population and increasing research funding will drive the segment growth.

Regionally, the Asia Pacific regenerative medicine industry will expand at a robust CAGR during 2023-2032. The growth can be attributed to the growing aging population and increasing healthcare infrastructure in the region. The rising investments in research and development and the rollout of favorable government initiatives will also contribute to the burgeoning demand for regenerative therapies in the region.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast calculation
  • 1.4 Covid-19 impact analysis at global level
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Secondary
      • 1.6.1.1 Paid sources
      • 1.6.1.2 Public sources
    • 1.6.2 Primary

Chapter 2 Executive Summary

  • 2.1 Regenerative medicine industry 360 degree synopsis, 2018 - 2032 (USD Million)
    • 2.1.1 Business trends
    • 2.1.2 Region trends
    • 2.1.3 Type trends
    • 2.1.4 Application trends

Chapter 3 Regenerative Medicine Market Insights

  • 3.1 Industry landscape, 2018 - 2032 (USD Million)
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing prevalence of chronic diseases worldwide
      • 3.2.1.2 Rising investment in development of innovative medicines
      • 3.2.1.3 High adoption of stem cell technology in disease treatment
      • 3.2.1.4 Strong product pipeline of potential therapies
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Stringent regulatory framework
      • 3.2.2.2 High cost associated with some regenerative medicine therapy
  • 3.3 Growth potential analysis
    • 3.3.1 By type
    • 3.3.2 By application
  • 3.4 COVID-19 impact analysis
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Global company market share analysis, 2022
  • 4.4 Competitive positioning matrix, 2022
  • 4.5 Strategic dashboard, 2022

Chapter 5 Regenerative Medicine Market Estimates and Forecast, By Type, 2018-2032 (USD Million)

  • 5.1 Key trends, by type
  • 5.2 Cell therapy
  • 5.3 Tissue engineering
  • 5.4 Gene therapy
  • 5.5 Other types

Chapter 6 Regenerative Medicine Market Estimates and Forecast, By Application, 2018-2032 (USD Million)

  • 6.1 Key trends, by application
  • 6.2 Oncology
  • 6.3 Musculoskeletal
  • 6.4 Neurology
  • 6.5 Cardiovascular
  • 6.6 Wound healing
  • 6.7 Ophthalmology
  • 6.8 Other applications

Chapter 7 Regenerative Medicine Market Estimates and Forecast, By Region, 2018-2032 (USD Million)

  • 7.1 Key trends, by region
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Spain
    • 7.3.5 Italy
    • 7.3.6 Sweden
    • 7.3.7 The Netherlands
    • 7.3.8 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 South Korea
    • 7.4.6 Rest of Asia Pacific
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
    • 7.5.4 Rest of Latin America
  • 7.6 Middle East & Africa
    • 7.6.1 South Africa
    • 7.6.2 Saudi Arabia
    • 7.6.3 UAE
    • 7.6.4 Rest of Middle East & Africa

Chapter 8 Company Profiles

  • 8.1 Novartis AG
  • 8.2 Amgen Inc.
  • 8.3 Bristol Myers Squibb
  • 8.4 BLUEBIRD BIO
  • 8.5 GC Pharma
  • 8.6 GlaxoSmithKline plc
  • 8.7 ANTEROGEN
  • 8.8 BIOSOLUTIONS
  • 8.9 TERUMO BCT
  • 8.10 AVITA MEDICAL
  • 8.11 Smith and Nephew
  • 8.12 ORGANOGENESIS

Data Tables

  • TABLE 1 Product mapping
  • TABLE 2 Market revenue, by type (2022)
  • TABLE 3 Market revenue, by application (2022)
  • TABLE 4 Market share, by region (2022)
  • TABLE 5 Global regenerative medicine market size, by region, 2018 - 2022 (USD Million)
  • TABLE 6 Global regenerative medicine market size, by region, 2023 - 2032 (USD Million)
  • TABLE 7 Global regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 8 Global regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 9 Global regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 10 Global regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 11 Industry impact forces
  • TABLE 12 Competitive benchmarking of major market players
  • TABLE 13 Competitive positioning matrix: Classification criteria
  • TABLE 14 Strategic outlook matrix: Classification criteria
  • TABLE 15 Cell therapy market size, by region, 2018 - 2022 (USD Million)
  • TABLE 16 Cell therapy market size, by region, 2023 - 2032 (USD Million)
  • TABLE 17 Tissue engineering market size, by region, 2018 - 2022 (USD Million)
  • TABLE 18 Tissue engineering market size, by region, 2023 - 2032 (USD Million)
  • TABLE 19 Gene therapy market size, by region, 2018 - 2022 (USD Million)
  • TABLE 20 Gene therapy market size, by region, 2023 - 2032 (USD Million)
  • TABLE 21 Other types market size, by region, 2018 - 2022 (USD Million)
  • TABLE 22 Other types market size, by region, 2023 - 2032 (USD Million)
  • TABLE 23 Oncology market size, by region, 2018 - 2022 (USD Million)
  • TABLE 24 Oncology market size, by region, 2023 - 2032 (USD Million)
  • TABLE 25 Musculoskeletal market size, by region, 2018 - 2022 (USD Million)
  • TABLE 26 Musculoskeletal market size, by region, 2023 - 2032 (USD Million)
  • TABLE 27 Neurology market size, by region, 2018 - 2022 (USD Million)
  • TABLE 28 Neurology market size, by region, 2023 - 2032 (USD Million)
  • TABLE 29 Cardiovascular market size, by region, 2018 - 2022 (USD Million)
  • TABLE 30 Cardiovascular market size, by region, 2023 - 2032 (USD Million)
  • TABLE 31 Wound healing market size, by region, 2018 - 2022 (USD Million)
  • TABLE 32 Wound healing market size, by region, 2023 - 2032 (USD Million)
  • TABLE 33 Ophthalmology market size, by region, 2018 - 2022 (USD Million)
  • TABLE 34 Ophthalmology market size, by region, 2023 - 2032 (USD Million)
  • TABLE 35 Other applications market size, by region, 2018 - 2022 (USD Million)
  • TABLE 36 Other applications market size, by region, 2023 - 2032 (USD Million)
  • TABLE 37 North America regenerative medicine market size, by country, 2018 - 2022 (USD Million)
  • TABLE 38 North America regenerative medicine market size, by country, 2023 - 2032 (USD Million)
  • TABLE 39 North America regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 40 North America regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 41 North America regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 42 North America regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 43 U.S. regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 44 U.S. regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 45 U.S. regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 46 U.S. regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 47 Canada regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 48 Canada regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 49 Canada regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 50 Canada regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 51 Europe regenerative medicine market size, by country, 2018 - 2022 (USD Million)
  • TABLE 52 Europe regenerative medicine market size, by country, 2023 - 2032 (USD Million)
  • TABLE 53 Europe regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 54 Europe regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 55 Europe regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 56 Europe regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 57 Germany regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 58 Germany regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 59 Germany regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 60 Germany regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 61 UK regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 62 UK regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 63 UK regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 64 UK regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 65 France regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 66 France regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 67 France regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 68 France regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 69 Spain regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 70 Spain regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 71 Spain regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 72 Spain regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 73 Italy regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 74 Italy regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 75 Italy regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 76 Italy regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 77 Sweden regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 78 Sweden regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 79 Sweden regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 80 Sweden regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 81 The Netherlands regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 82 The Netherlands regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 83 The Netherlands regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 84 The Netherlands regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 85 Rest of Europe regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 86 Rest of Europe regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 87 Rest of Europe regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 88 Rest of Europe regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 89 Asia Pacific regenerative medicine market size, by country, 2018 - 2022 (USD Million)
  • TABLE 90 Asia Pacific regenerative medicine market size, by country, 2023 - 2032 (USD Million)
  • TABLE 91 Asia Pacific regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 92 Asia Pacific regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 93 Asia Pacific regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 94 Asia Pacific regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 95 China regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 96 China regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 97 China regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 98 China regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 99 Japan regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 100 Japan regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 101 Japan regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 102 Japan regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 103 India regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 104 India regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 105 India regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 106 India regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 107 Australia regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 108 Australia regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 109 Australia regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 110 Australia regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 111 South Korea regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 112 South Korea regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 113 South Korea regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 114 South Korea regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 115 Rest of Asia Pacific regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 116 Rest of Asia Pacific regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 117 Rest of Asia Pacific regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 118 Rest of Asia Pacific regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 119 Latin America regenerative medicine market size, by country, 2018 - 2022 (USD Million)
  • TABLE 120 Latin America regenerative medicine market size, by country, 2023 - 2032 (USD Million)
  • TABLE 121 Latin America regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 122 Latin America regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 123 Latin America regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 124 Latin America regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 125 Brazil regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 126 Brazil regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 127 Brazil regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 128 Brazil regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 129 Mexico regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 130 Mexico regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 131 Mexico regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 132 Mexico regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 133 Argentina regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 134 Argentina regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 135 Argentina regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 136 Argentina regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 137 Rest of Latin America regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 138 Rest of Latin America regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 139 Rest of Latin America regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 140 Rest of Latin America regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 141 Middle East & Africa regenerative medicine market size, by country, 2018 - 2022 (USD Million)
  • TABLE 142 Middle East & Africa regenerative medicine market size, by country, 2023 - 2032 (USD Million)
  • TABLE 143 Middle East & Africa regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 144 Middle East & Africa regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 145 Middle East & Africa regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 146 Middle East & Africa regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 147 South Africa regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 148 South Africa regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 149 South Africa regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 150 South Africa regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 151 Saudi Arabia regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 152 Saudi Arabia regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 153 Saudi Arabia regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 154 Saudi Arabia regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 155 UAE regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 156 UAE regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 157 UAE regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 158 UAE regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 159 Rest of Middle East & Africa regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 160 Rest of Middle East & Africa regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 161 Rest of Middle East & Africa regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 162 Rest of Middle East & Africa regenerative medicine market size, by application, 2023 - 2032 (USD Million)

Charts & Figures

  • FIG 1 GMI report coverage: Critical research elements
  • FIG 2 Top-down approach
  • FIG 3 Market estimation and forecast methodology
  • FIG 4 Market forecasting methodology
  • FIG 5 Breakdown of primary participants
  • FIG 6 Regenerative medicine industry 36 degree synopsis, 2018 - 2032
  • FIG 7 Growth potential analysis, by type
  • FIG 8 Growth potential analysis, by application
  • FIG 9 Porter's analysis
  • FIG 10 PESTEL analysis
  • FIG 11 Company matrix analysis, 2022
  • FIG 12 Global company market share analysis, 2022
  • FIG 13 Competitive positioning matrix, 2022
  • FIG 14 Strategic dashboard, 2022